MEA Pigmented Lesion Treatment Market

MEA Pigmented Lesion Treatment Market Size (2023 to 2028)

The size of the Pigmented Lesion Treatment Market in the Middle East and Africa is estimated to witness a healthy CAGR from 2023 to 2028.

Growing stipulation for treatment procedures for quick healing and the existence of well-established healthcare infrastructure are stimulating the market growth. The growing necessity for dermatology techniques and increasing beauty consciousness in both men and women is predicted to drive the market. People aged 60 years and above are stimulated to augment around 962 million in 2017 to 2.1 billion by 2050, according to the World Health Organization (WHO). Advance technologies in therapy processes comprising a laser and energy-based treatments for pigmented lesions are likely to expand the market growth. The latest and newly introduced therapies can remove forms of skin effects of the vascular and pigmented lesion with no side effects.

A laser treatment used at the time of treating patients may have some side-effects like skin itching, rashes, scar, skin becomes red, and swelling of the skin, and in some rare cases, infections and hyperpigmentation can occur, which may hamper the growth. The cost associated with the pigmented lesion treatment is very expensive, which is unaffordable. Lack of knowledge about the treatment is limiting the demand of the market.

This research report on the MEA Pigmented Lesion Treatment Market has been segmented and sub-segmented into the following categories:

• By Product: Energy-Based Devices, RF Devices, Ultrasound Devices, and IPL Devices
• By End User: Beauty Clinics and Dermatology Clinics
• By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Regional Analysis:

The Middle East & Africa region is accounted to have steady, minimal, and average growth rates over the period. It is estimated to project a healthy growth rate in the upcoming years. The growth is ascribed due to factors like varying lifestyles, growing cravings for smoking, and increased alcohol intake. Also, escalation in an inactive lifestyle and expenses on the region's healthcare services domain may impel the market growth.

UAE is projected to lead the pigmented lesion treatment in the MEA region. Factors like rising in old people population, growing assumption of human-made cosmetic commodities, and presentation of experimental medications and therapy are likely to surge the region's market growth. Africa is forecasted to have rapid growth in the pigmented lesion treatment market of MEA. 1in every 5,000 to 15,000people in Africa have albinism. The frequency of albinism is high in African countries. An increasing number of hospitals and dermatology clinics, exposure to heavy sun-rays, and the introduction of non-invasive med-aesthetic systems that can efficiently decrease the consequences drive the market growth in MEA.

The MEA Pigmented Lesion Treatment Market is dominated by companies like Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd, Solta Medical Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc.